首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1391912

甲硫酸新斯狄格明注射液市場：依劑量、適應症、依通路、依最終用途、依地區

Neostigmine Methylsulfate Injection Market, By Dosage, By Indication, By Distribution Channel, By End Use, By Geography

出版日期: 2023年11月09日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

甲硫酸新斯狄格明注射液的全球市場規模預計到2023年為1.567億美元，預計到2030年將達到2.133億美元，預測期內複合年成長率為4.5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	1.567 億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	4.50%	2030年市場規模預測	2.133 億美元

圖1. 2023年甲硫酸新斯狄格明注射液依地區分類的全球市場佔有率（%）

甲硫酸新斯狄格明注射液是一種膽鹼酯酶抑制劑，用作治療重症肌無力的輔助藥物，也可作為手術室和加護病房非去極化神經肌肉阻斷劑毒性的解毒劑。該藥物透過抑制乙醯膽鹼酯酶而發揮作用，乙醯膽鹼酯酶會分解神經肌肉接頭處的神經肌肉傳導物質乙醯膽鹼。透過抑制這種酶，甲硫酸新斯狄格明可以延長乙醯膽鹼的作用，並增加神經肌肉傳遞和肌肉力量。它可用於治療重症肌無力的症狀，例如四肢、身體軀幹、喉嚨、眼睛等骨骼肌的肌肉無力。如果服用給藥或過敏的患者，神經肌肉接頭的刺激可能會增加，引起噁心、流涎增加和肌肉痙攣等副作用。

市場動態：

在預測期內，老年人口的增加也可能推動全球甲硫酸新斯狄格明注射液市場的成長。老年人更容易患重症肌無力等神經系統疾病，通常需要注射甲硫酸新斯狄格明來治療。在預測期內，醫療保健成本的上升也可能繼續推動全球甲硫酸新斯狄格明注射液市場的成長。在預測期內，獸藥的成長可能為全球甲硫酸新斯狄格明注射液市場創造新的機會。甲硫酸新斯狄格明注射液也用於獸醫，特別是用於治療動物的多種神經肌肉疾病。增加甲硫酸新斯狄格明注射液在獸醫行業的使用和可得性可能會開闢新的商業性前景。

缺乏知識和診斷預計將阻礙預測期內全球甲硫酸新斯狄格明注射液市場的成長。

本研究的主要特點

本報告對全球甲硫酸新斯狄格明注射液市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個區隔市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，對全球甲硫酸新斯狄格明注射液市場的主要參與者進行了分析。
本研究涵蓋的主要企業包括 Baxter International Inc.、Pfizer Inc.、Fresenius Kabi AG、Boehringer Ingelheim GmbH、Mylan NV、Novartis International AG、Teva Pharmaceutical Industries Ltd.、Hikma Pharmaceuticals PLC、、GlaxoSmithKline plclc、Sun Industries Ltd.、Hikma Pharmaceuticals PLC、、GlaxoSmithKline plclc、Sun Industries Ltd.、Hikma Pharmaceuticals PLC、、GlaxoSmithKline plclc、Sun Industries Ltd.、Hikma Pharmaceuticals PLC、、GlaxoSmithKline plclc. Ltd.、Sandoz（諾華公司的子公司）、Accord Healthcare Inc.、Lannett Company, Inc.、Mallinckrodt Pharmaceuticals 和Lupin Limited。
從這份報告中獲得的見解將幫助行銷人員和經營團隊就未來的產品發布、升級、市場擴張和行銷策略負責人資訊的決策。
全球甲硫酸新斯狄格明注射液市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
透過用於分析全球甲硫酸新斯狄格明注射液市場的各種策略矩陣，將促進相關人員的決策。

介紹
2023年及2030年市場佔有率分析（%）
與前一年同期比較成長分析，2019-2030
區隔市場趨勢
重症肌無力
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率
神經肌肉阻斷的逆轉
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率

第7章2018-2030年全球甲硫酸新斯狄格明注射液市場（依配銷通路）

介紹
2023年及2030年市場佔有率分析（%）
與前一年同期比較成長分析，2019-2030
區隔市場趨勢
醫院藥房
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率
零售藥房
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率
線上藥房
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率

第8章2018-2030年全球硫酸甲酯新斯的明注射液市場（依最終用戶分類）

介紹
2023年及2030年市場佔有率分析（%）
與前一年同期比較成長分析，2019-2030
區隔市場趨勢
醫院
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率
專科診所
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率
門診手術中心
介紹
2018-2030年市場規模及預測、與前一年同期比較成長率

第9章2018-2030年全球硫酸甲酯新斯的明注射液市場（分地區）

介紹
2023 年及 2030 年依地區分類的市場佔有率分析 (%)
2019-2030 年地區與前一年同期比較成長分析
各國的趨勢
北美洲
介紹
2018-2030 年市場規模與劑量預測、與前一年同期比較成長率
2018-2030年市場規模及依指標預測、與前一年同期比較成長率
2018-2030年依配銷通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
2018-2030 年市場規模及各國預測、與前一年同期比較成長率
美國
加拿大
歐洲
介紹
2018-2030 年市場規模與劑量預測、與前一年同期比較成長率
2018-2030年市場規模及依指標預測、與前一年同期比較成長率
2018-2030年依配銷通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
2018-2030 年市場規模及各國預測、與前一年同期比較成長率
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
介紹
2018-2030 年市場規模與劑量預測、與前一年同期比較成長率
2018-2030年市場規模及依指標預測、與前一年同期比較成長率
2018-2030年依配銷通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
2018-2030 年市場規模及各國預測、與前一年同期比較成長率
中國
印度
日本
東南亞國協
澳洲
韓國
其他亞太地區
拉丁美洲
介紹
2018-2030 年市場規模與劑量預測、與前一年同期比較成長率
2018-2030年市場規模及依指標預測、與前一年同期比較成長率
2018-2030年依配銷通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
2018-2030 年市場規模及各國預測、與前一年同期比較成長率
巴西
墨西哥
阿根廷
其他拉丁美洲
中東和非洲
介紹
2018-2030 年市場規模與劑量預測、與前一年同期比較成長率
2018-2030年市場規模及依指標預測、與前一年同期比較成長率
2018-2030年依配銷通路分類的市場規模與預測、與前一年同期比較成長率
2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
2018-2030 年市場規模及各國預測、與前一年同期比較成長率
海灣合作理事會國家
以色列
其他中東地區
北非
中部非洲
南非

第10章競爭形勢

Baxter International Inc.
Pfizer Inc.
Fresenius Kabi AG
Boehringer Ingelheim GmbH
Mylan NV
Novartis International AG
Teva Pharmaceutical Industries Ltd.
Hikma Pharmaceuticals PLC
GlaxoSmithKline plc
Sun Pharmaceutical Industries Ltd.
Sandoz（a division of Novartis）
Accord Healthcare Inc.
Lannett Company, Inc.
Mallinckrodt Pharmaceuticals
Lupin Limited

第11章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6033

The global neostigmine methylsulfate injection market size is projected to be valued at US$ 156.7 Mn in 2023 and is projected to reach US$ 213.3 Mn by 2030, registering a CAGR of 4.5% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 156.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.50%	2030 Value Projection:	US$ 213.3 Mn

Figure 1. Global Neostigmine Methylsulfate Injection Market Share (%), by Region, 2023

Neostigmine Methylsulfate Injection Market - IMG1

Neostigmine methylsulfate injection is a cholinesterase inhibitor that is used as an adjunct in the treatment of myasthenia gravis and as an antidote in the treatment of non-depolarizing neuromuscular blocking agent toxicity in the operating room or intensive care unit setting. It acts by inhibiting the acetylcholinesterase enzyme, which normally breaks down the neurotransmitter acetylcholine at the neuromuscular junction. By inhibiting this enzyme, neostigmine methylsulfate prolongs the actions of acetylcholine, increasing neuromuscular transmission and muscle strength. It helps in the management of myasthenia gravis symptoms such as weakness of the skeletal muscles of the extremities, trunk, throat, and eyes. In overdose or sensitive patients, it can cause increased stimulation at the neuromuscular junction and produce side effects such as nausea, increased saliva, and muscle cramps.

Market Dynamics:

The increasing geriatric population will continue to fuel the growth of the global neostigmine methylsulfate injection market over the forecast period. The elderly are more susceptible to neurological conditions like myasthenia gravis, which frequently needs to be treated with injections of neostigmine methylsulfate. Rising medical expenditures will also continue to fuel the growth of the global neostigmine methylsulfate injection market over the forecast period. The growth of veterinary medicine will create new opportunities for the global neostigmine methylsulfate injection market over the forecast period. Injections of neostigmine methylsulfate are also employed in veterinary medicine, particularly for the treatment of a few neuromuscular diseases in animals. It may open up new commercial prospects to increase the use and availability of neostigmine methylsulfate injections in the veterinary industry.

Lack of knowledge and diagnosis is expected to hamper the growth of the global neostigmine methylsulfate injection market over the forecast period.

Key Features of the Study:

This report provides an in-depth analysis of the global neostigmine methylsulfate injection market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neostigmine methylsulfate injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Baxter International Inc., Pfizer Inc., Fresenius Kabi AG, Boehringer Ingelheim GmbH, Mylan N.V., Novartis International AG, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Sandoz (a division of Novartis), Accord Healthcare Inc., Lannett Company, Inc., Mallinckrodt Pharmaceuticals, and Lupin Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neostigmine methylsulfate injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neostigmine methylsulfate injection market

Detailed Segmentation:

Global Neostigmine Methylsulfate Injection Market, By Dosage:
- 1 mg/mL
- 0.5 mg/mL
Global Neostigmine Methylsulfate Injection Market, By Indications:
- Myasthenia Gravis
- Reversal of Neuromuscular Blockade
Global Neostigmine Methylsulfate Injection Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Neostigmine Methylsulfate Injection Market, By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Global Neostigmine Methylsulfate Injection Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Baxter International Inc.
- Pfizer Inc.
- Fresenius Kabi AG
- Boehringer Ingelheim GmbH
- Mylan N.V.
- Novartis International AG
- Teva Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries Ltd.
- Sandoz (a division of Novartis)
- Accord Healthcare Inc.
- Lannett Company, Inc.
- Mallinckrodt Pharmaceuticals
- Lupin Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Neostigmine Methylsulfate Injection Market, By Dosage
- Neostigmine Methylsulfate Injection Market, By Indication
- Neostigmine Methylsulfate Injection Market, By Distribution Channel
- Neostigmine Methylsulfate Injection Market, By End User
- Neostigmine Methylsulfate Injection Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
Restraints
Lack of knowledge and diagnosis
Opportunities
Growth of veterinary medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Neostigmine Methylsulfate Injection Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Neostigmine Methylsulfate Injection Market, By Dosage, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
1 mg/mL
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
0.5 mg/mL
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Global Neostigmine Methylsulfate Injection Market, By Indication, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Myasthenia Gravis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Reversal of Neuromuscular Blockade
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Global Neostigmine Methylsulfate Injection Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Neostigmine Methylsulfate Injection Market, By End User, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Global Neostigmine Methylsulfate Injection Market, By Region, 2018-2030, (US$ Mn)

Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Region 2019 - 2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
North Africa
Central Africa
South Africa